Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease

Byoung Dae Lee, Joo Ho Shin, Jackalina Vankampen, Leonard Petrucelli, Andrew B. West, Han Seok Ko, Yun Il Lee, Kathleen A. Maguire-Zeiss, William J. Bowers, Howard J. Federoff, Valina L. Dawson, Ted M. Dawson

Research output: Contribution to journal › Article

245 Citations (Scopus)

Abstract

Leucine-rich repeat kinase-2 (LRRK2) mutations are a common cause of Parkinson's disease. Here we identify inhibitors of LRRK2 kinase that are protective in in vitro and in vivo models of LRRK2-induced neurodegeneration. These results establish that LRRK2-induced degeneration of neurons in vivo is kinase dependent and that LRRK2 kinase inhibition provides a potential new neuroprotective paradigm for the treatment of Parkinson's disease.

Original languageEnglish (US)
Pages (from-to)998-1000
Number of pages3
JournalNature Medicine
Volume16
Issue number9
DOIs
StatePublished - Sep 2010

Fingerprint

Leucine
Parkinson Disease
Phosphotransferases
Nerve Degeneration
Neurons
Mutation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Lee, B. D., Shin, J. H., Vankampen, J., Petrucelli, L., West, A. B., Ko, H. S., ... Dawson, T. M. (2010). Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. Nature Medicine, 16(9), 998-1000. https://doi.org/10.1038/nm.2199

Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. / Lee, Byoung Dae; Shin, Joo Ho; Vankampen, Jackalina; Petrucelli, Leonard; West, Andrew B.; Ko, Han Seok; Lee, Yun Il; Maguire-Zeiss, Kathleen A.; Bowers, William J.; Federoff, Howard J.; Dawson, Valina L.; Dawson, Ted M.

In: Nature Medicine, Vol. 16, No. 9, 09.2010, p. 998-1000.

Research output: Contribution to journal › Article

Lee, BD, Shin, JH, Vankampen, J, Petrucelli, L, West, AB, Ko, HS, Lee, YI, Maguire-Zeiss, KA, Bowers, WJ, Federoff, HJ, Dawson, VL & Dawson, TM 2010, 'Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease', Nature Medicine, vol. 16, no. 9, pp. 998-1000. https://doi.org/10.1038/nm.2199
Lee BD, Shin JH, Vankampen J, Petrucelli L, West AB, Ko HS et al. Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. Nature Medicine. 2010 Sep;16(9):998-1000. https://doi.org/10.1038/nm.2199
Lee, Byoung Dae ; Shin, Joo Ho ; Vankampen, Jackalina ; Petrucelli, Leonard ; West, Andrew B. ; Ko, Han Seok ; Lee, Yun Il ; Maguire-Zeiss, Kathleen A. ; Bowers, William J. ; Federoff, Howard J. ; Dawson, Valina L. ; Dawson, Ted M. / Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. In: Nature Medicine. 2010 ; Vol. 16, No. 9. pp. 998-1000.
@article{143f06ea9cf74928baba46111efba7c2,
title = "Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease",
abstract = "Leucine-rich repeat kinase-2 (LRRK2) mutations are a common cause of Parkinson's disease. Here we identify inhibitors of LRRK2 kinase that are protective in in vitro and in vivo models of LRRK2-induced neurodegeneration. These results establish that LRRK2-induced degeneration of neurons in vivo is kinase dependent and that LRRK2 kinase inhibition provides a potential new neuroprotective paradigm for the treatment of Parkinson's disease.",
author = "Lee, {Byoung Dae} and Shin, {Joo Ho} and Jackalina Vankampen and Leonard Petrucelli and West, {Andrew B.} and Ko, {Han Seok} and Lee, {Yun Il} and Maguire-Zeiss, {Kathleen A.} and Bowers, {William J.} and Federoff, {Howard J.} and Dawson, {Valina L.} and Dawson, {Ted M.}",
year = "2010",
month = "9",
doi = "10.1038/nm.2199",
language = "English (US)",
volume = "16",
pages = "998--1000",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease

AU - Lee, Byoung Dae

AU - Shin, Joo Ho

AU - Vankampen, Jackalina

AU - Petrucelli, Leonard

AU - West, Andrew B.

AU - Ko, Han Seok

AU - Lee, Yun Il

AU - Maguire-Zeiss, Kathleen A.

AU - Bowers, William J.

AU - Federoff, Howard J.

AU - Dawson, Valina L.

AU - Dawson, Ted M.

PY - 2010/9

Y1 - 2010/9

N2 - Leucine-rich repeat kinase-2 (LRRK2) mutations are a common cause of Parkinson's disease. Here we identify inhibitors of LRRK2 kinase that are protective in in vitro and in vivo models of LRRK2-induced neurodegeneration. These results establish that LRRK2-induced degeneration of neurons in vivo is kinase dependent and that LRRK2 kinase inhibition provides a potential new neuroprotective paradigm for the treatment of Parkinson's disease.

AB - Leucine-rich repeat kinase-2 (LRRK2) mutations are a common cause of Parkinson's disease. Here we identify inhibitors of LRRK2 kinase that are protective in in vitro and in vivo models of LRRK2-induced neurodegeneration. These results establish that LRRK2-induced degeneration of neurons in vivo is kinase dependent and that LRRK2 kinase inhibition provides a potential new neuroprotective paradigm for the treatment of Parkinson's disease.

UR - http://www.scopus.com/inward/record.url?scp=77956441086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956441086&partnerID=8YFLogxK

U2 - 10.1038/nm.2199

DO - 10.1038/nm.2199

M3 - Article

C2 - 20729864

AN - SCOPUS:77956441086

VL - 16

SP - 998

EP - 1000

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 9

ER -

Access to Document